Cibc Asset Management Inc Neurocrine Biosciences Inc Transaction History

Cibc Asset Management Inc

$28.3 Billion
Q3 2024

A detailed history of Cibc Asset Management Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Cibc Asset Management Inc holds 3,591 shares of NBIX stock, worth $451,209. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,591

Previous 3,400 5.62%

Holding current value

$451,209

Previous $468,000 11.75%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$114.58 - $153.15 $21,884 - $29,251	191 Added 5.62%	3,591 $413,000
Q2 2024 Aug 01, 2024	BUY	$130.86 - $143.19 $20,021 - $21,908	153 Added 4.71%	3,400 $468,000
Q1 2024 May 09, 2024	BUY	$130.4 - $143.74 $912 - $1,006	7 Added 0.22%	3,247 $447,000
Q4 2023 Feb 13, 2024	SELL	$106.07 - $132.76 $24,290 - $30,402	-229 Reduced 6.6%	3,240 $426,000
Q3 2023 Oct 30, 2023	BUY	$94.02 - $117.1 $4,512 - $5,620	48 Added 1.4%	3,469 $390,000
Q2 2023 Aug 14, 2023	BUY	$89.53 - $104.87 $268 - $314	3 Added 0.09%	3,421 $322,000
Q1 2023 May 12, 2023	BUY	$94.11 - $123.02 $30,585 - $39,981	325 Added 10.51%	3,418 $345,000
Q4 2022 Feb 13, 2023	SELL	$106.72 - $127.06 $124,115 - $147,770	-1,163 Reduced 27.33%	3,093 $369,000
Q3 2022 Nov 03, 2022	BUY	$92.03 - $107.81 $1,104 - $1,293	12 Added 0.28%	4,256 $452,000
Q2 2022 Aug 09, 2022	SELL	$75.79 - $100.07 $4,471 - $5,904	-59 Reduced 1.37%	4,244 $414,000
Q1 2022 May 06, 2022	BUY	$72.45 - $94.81 $1,738 - $2,275	24 Added 0.56%	4,303 $403,000
Q4 2021 Feb 08, 2022	BUY	$79.65 - $106.22 $33,691 - $44,931	423 Added 10.97%	4,279 $364,000
Q3 2021 Nov 09, 2021	BUY	$86.18 - $99.03 $29,128 - $33,472	338 Added 9.61%	3,856 $370,000
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $536 - $613	6 Added 0.17%	3,518 $342,000
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $939,976 - $1.28 Million	-10,734 Reduced 75.35%	3,512 $342,000
Q4 2020 Feb 03, 2021	BUY	$86.91 - $108.33 $71,092 - $88,613	818 Added 6.09%	14,246 $1.37 Million
Q3 2020 Nov 05, 2020	BUY	$96.16 - $135.15 $966,696 - $1.36 Million	10,053 Added 297.87%	13,428 $1.29 Million
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $16,839 - $23,002	194 Added 6.1%	3,375 $363,000
Q2 2018 Aug 09, 2018	BUY	$75.3 - $105.99 $16,189 - $22,787	215 Added 7.25%	3,181 $313,000
Q4 2017 Feb 02, 2018	BUY	$58.53 - $77.59 $173,599 - $230,131	2,966	2,966 $230,000

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Account

Cibc Asset Management Inc Neurocrine Biosciences Inc Transaction History